Patent Assignment
Reel/Frame 030230/0777
Assignment of Assignor's Interest
Recorded: 2013-04-17
Pages: 15
Assignor
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Executed: 2010-08-16
Assignee
HYBRID BIOSYSTEMS LIMITED
77 HEYFORD PARK, UPPER HEYFORD, CHERWELL INNOVATION CENTRE, OXFORDSHIRE, OX25 5HD, UNITED KINGDOM
Covered Property
(1)
Chimeric Adenoviruses for Use in Cancer Treatment
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 17, 2013
From: HARDEN, PAUL; HERMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 030230/0685 →
Assignment of Assignor's Interest
Apr 17, 2013
From: HYBRID BIOSYSTEMS LIMITED
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 030230/0819 →
Change of Name
Apr 17, 2013
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030230/0836 →
Change of Name
Feb 8, 2023
From: PSIOXUS THERAPEUTICS LIMITED
To: AKAMIS BIO LIMITED
Reel/Frame 062681/0495 →
Change of Address
Feb 8, 2023
From: AKAMIS BIO LIMITED
To: AKAMIS BIO LIMITED
Reel/Frame 062681/0504 →
Assignment of Assignor's Interest
Jan 23, 2026
From: AKAMIS BIO LIMITED
To: AKAMIS BIO, INC.
Reel/Frame 073559/0435 →